The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 14 of the 19 sources its claims cite were checked for support.
Livebirth rate after one frozen embryo transfer in ovulatory women starting with natural, modified natural, or artificial endometrial preparation in Viet Nam: an open-label randomised controlled trial.
Open accessAbstract
Use of frozen embryo transfer (FET) in in-vitro fertilisation (IVF) has increased. However, the best endometrial preparation protocol for FET cycles is unclear. We compared natural and modified natural cycle strategies with an artificial cycle strategy for endometrial preparation before FET. In this randomised, open-label study, we recruited ovulatory women aged 18-45 years at a hospital in Ho Chi Minh City, Viet Nam, who were randomly allocated (1:1:1) to natural, modified natural, or artificial cycle endometrial preparation using a computer-generated random list and block randomisation. The trial was not masked due to the nature of the study interventions. In natural cycles, no oestrogen, progesterone, or human chorionic gonadotropin (hCG) was used. In modified natural cycles, hCG was used to trigger ovulation. In artificial cycles, oral oestradiol valerate (8 mg/day from day 2-4 of menstruation) and vaginal progesterone (800 mg/day starting when endometrial thickness was ≥7 mm) were used. Embryos were vitrified, and then one or two day-3 embryos or one day-5 embryo were warmed and transferred under ultrasound guidance. If the first FET cycle was cancelled, subsequent cycles were performed with artificial endometrial preparation. The primary endpoint was livebirth after one FET. This trial is registered at ClinicalTrials.gov, NCT04804020. Between March 22, 2021, and March 14, 2023, 4779 women were screened and 1428 were randomly assigned (476 to each group). 99 first FET cy…
Overview
CoChat Summary
TL;DR
In ovulatory women undergoing frozen embryo transfer (FET), starting endometrial preparation with a natural, modified natural, or artificial cycle produced similar livebirth rates after one FET. However, natural and modified natural strategies had a 21% first-cycle cancellation rate versus 0% with artificial cycles, and the trial was not powered to assess safety differences.
Key findings
- Livebirth after one FET occurred in 174/476 (37%) in the natural cycle strategy group, 159/476 (33%) in the modified natural cycle strategy group, and 162/476 (34%) in the artificial cycle strategy group.
- Compared with artificial cycles, the relative risk was 1·07 (95% CI 0·87–1·33) for natural cycles and 0·98 (95% CI 0·79–1·22) for modified natural cycles.
- First endometrial preparation cycle cancellation occurred in 99/476 (21%) natural cycles and 99/476 (21%) modified natural cycles, versus 0/476 artificial cycles.
- Maternal and neonatal outcomes did not differ significantly between groups, but the authors state the power to detect small differences was low.
Methods
- Single-centre, open-label randomised controlled trial at IVFMD, My Duc Hospital, Ho Chi Minh City, Viet Nam; 4779 women were screened and 1428 ovulatory women aged 18–45 years with regular menstrual cycles were randomly assigned 1:1:1 to natural, modified natural, or artificial endometrial preparation.
- Natural cycles used no oestrogen, progesterone, or hCG; modified natural cycles used hCG to trigger ovulation; artificial cycles used oral oestradiol valerate 8 mg/day and vaginal progesterone 800 mg/day once endometrial thickness was ≥7 mm.
- The primary outcome was livebirth after one FET; primary analysis was intention-to-treat, with Fisher’s exact test for the primary outcome and relative risks with 95% CIs reported.
Limitations
- The authors report that the open-label design was unavoidable, but note livebirth and other outcomes are objective and unlikely to be affected by detection bias.
- The authors state the trial was not powered to detect between-group differences in maternal and neonatal complications, and the power calculation was based on a 10% between-group difference in livebirth rate, meaning a small benefit of one strategy cannot be excluded.
- The authors note limited generalisability because participants were ovulatory women from a single centre in Viet Nam, a quarter of eligible women declined participation, the upper age limit was 45 years, and 35% had double embryo transfer; acceptability data were not collected.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
10 Valid · 1 Not valid · 2 Not checked · 58 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In addition, previous trials 16,21-23 considered cancellation cycles to be the same as unsuccessful cycles after FET.”
What the sources say
- Supportedcites [16] Groenewoud, 2016, A randomized controlled, non-inferiority trial of modified natural versus artificial cycle for cryo-thawed embryo transfer, Hum Reprod source
The Materials and Methods section says the primary live-birth analysis followed intention-to-treat principles. In the Results, live births are reported per started treatment cycle (57/495 and 41/464), so cancelled cycles remain in the denominators and count as cycles without a live birth; the paper separately reports rates per embryo transfer. It does not literally describe a cancelled cycle as an unsuccessful transfer. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [21] Liu, 2020, Natural cycle frozen-thawed embryo transfer in young women with regular menstrual cycles increases the live-birth rates compared with hormone replacement treatment: a retrospective cohort study, Fertil Steril source
- Could not verifycites [22] Mensing, 2022, Endometrial preparation methods prior to frozen embryo transfer: a retrospective cohort study comparing true natural cycle, modified natural cycle and artificial cycle, Arch Gynecol Obstet sourceExperimental — accuracy not yet measured
The Results (Outcomes; page unavailable) report cancellation rates and reasons for cancellation, but do not say how previous trials classified cancelled cycles. A search for cancelled cycles counted as unsuccessful FET cycles or failures found no passage addressing that practice. (LLM, conf=0.72)
- Could not verifycites [23] Vinsonneau, 2022, Impact of endometrial preparation on early pregnancy loss and live birth rate after frozen embryo transfer: a large multicenter cohort study (14 421 frozen cycles), Hum Reprod Open sourceExperimental — accuracy not yet measured
The Methods (Inclusion/exclusion criteria; page unavailable) require at least one frozen–thawed embryo transfer, and the Results report outcomes for included FET cycles. Neither section, nor the passages found by searching for cancellation and cancelled cycles, says that previous trials treated cancelled cycles as unsuccessful cycles after FET. (LLM, conf=0.73)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Existing data include a 2023 systematic review and meta-analysis, 7,25 which found significantly higher risks for several adverse obstetric and neonatal outcomes in artificial versus natural FET cycles.”
What the sources say
- Supportedcites [7] Zaat, 2023, Obstetric and neonatal outcomes after natural versus artificial cycle frozen embryo transfer and the role of luteal phase support: a systematic review and meta-analysis, Hum Reprod Update source
The Results > Outcomes section reports significantly lower odds of several adverse outcomes after natural-cycle than artificial-cycle FET, including preterm birth, hypertensive disorders of pregnancy, and postpartum hemorrhage; the reported 95% confidence intervals exclude 1. The Discussion > Principal findings also summarizes lower adverse obstetric and neonatal risks with natural-cycle FET. The review notes that its evidence came from observational studies and was of very low to moderate quality. (LLM, conf=0.93)
- Partly supportedcites [25] Lee, 2022, The impact of endometrial preparation for frozen embryo transfer on maternal and neonatal outcomes: a review, Reprod Biol Endocrinol sourceExperimental — accuracy not yet measured
The review’s ‘Maternal and neonatal outcomes by method of endometrial preparation’ section reports higher risks of several adverse obstetric and neonatal outcomes in programmed versus natural FET cycles. But this source is a 2022 review, not the 2023 systematic review and meta-analysis described in the citing sentence; our copy does not report a pooled meta-analysis of those outcomes. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, none of the included studies directly compared artificial, modified natural, and natural cycles.”
What the sources say
- Supportedcites [8] Ghobara, 2017, Cycle regimens for frozen-thawed embryo transfer, Cochrane Database Syst Rev source
The review’s comparison list (page unavailable) identifies separate studies comparing natural with artificial (HT), natural with modified natural, and modified natural with HT cycles. It lists no included study directly comparing all three regimens. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“159 (33%) of 476 in the modified natural cycle strategy group”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The livebirth rate after one FET was 174 (37%) of 476 in the natural cycle strategy group”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
27 more claims
Create a free account to see all 71 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 24
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion · p. 8
“| Preterm delivery 20 to <28 weeks' gestation, singletons | 0/163 | 0/151 | 1/155 (<1%)”
§ Discussion · p. 8
“| Preterm delivery 20 to <28 weeks' gestation, singletons | 4/11 (36%) | 4/8 (50%) | 2/7 (29%)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Summary · p. 2
“Maternal and neonatal outcomes did not differ significantly between groups, as the power to detect small differences was low.”
§ Discussion · p. 8
“| Admission to NICU | 15 (3%) | 8 (2%) | 18 (4%) | 0·83 (0·41 to 1·65) | 0·44 (0·18 to 0·99)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion · p. 8
“| Preterm delivery 32 to <37 weeks' gestation, twins | 4 (<1%) | 4 (<1%) | 2 (<1%)”
§ Discussion · p. 8
“| Preterm delivery 32 to <37 weeks' gestation, twins | 1/11 (9%) | 0/8 | 0/7”
Citations
Cites
The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting
Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, Balaban, B., Brison, D., Calderon, G., Catt, J., Conaghan, J., Cowan, L., Ebner, T., Gardner, D., Hardarson, T., et al. (2011) · Human Reproduction · doi:10.1093/humrep/der037 · Cited by 2,015
The International Glossary on Infertility and Fertility Care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.005 · Cited by 1,505
Self-citationThe international glossary on infertility and fertility care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex234 · Cited by 1,320
Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo
Trounson, A., & Mohr, L. (1983) · Nature · doi:10.1038/305707a0 · Cited by 1,126
Munro, M. G., Critchley, H. O. D., Fraser, I. S., & the FIGO Menstrual Disorders Committee (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12666 · Cited by 1,026
Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome
Chen, Z.-J., Shi, Y., Sun, Y., Zhang, B., Liang, X., Cao, Y., Yang, J., Liu, J., Wei, D., Weng, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513873 · Cited by 786
Rienzi, L., Gracia, C., Maggiulli, R., LaBarbera, A. R., Kaser, D. J., Ubaldi, F. M., Vanderpoel, S., & Racowsky, C. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw038 · Cited by 729
Cycle regimens for frozen-thawed embryo transfer
Ghobara, T., Gelbaya, T. A., & Ayeleke, R. O. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003414.pub3 · Cited by 468
Frozen embryo transfer: a review on the optimal endometrial preparation and timing
Mackens, S., Santos-Ribeiro, S., van de Vijver, A., Racca, A., Van Landuyt, L., Tournaye, H., & Blockeel, C. (2017) · Human Reproduction · doi:10.1093/humrep/dex285 · Cited by 361
Liu, K. E., Hartman, M., Hartman, A., Luo, Z. C., & Mahutte, N. (2018) · Human Reproduction · doi:10.1093/humrep/dey281 · Cited by 353
Research works printed but not linked: 1
- Cattoli, 1994, A randomized prospective study on cryopreserved-thawed embryo transfer: natural versus hormone replacement cycles, Human Reprod, 9, 139
Cited by
Liu, X., Li, W., Wen, W., Wang, T., Wang, T., Sun, T., Zhang, N., Pan, D., Xie, J., Liu, X., et al. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004630 · Cited by 29
Self-citationWei, D., Qin, Y., Sun, Y., Yan, J., Zhao, H., Guan, Y., Tan, J., Guo, T., Wang, Z., Gong, F., et al. (2026) · BMJ · doi:10.1136/bmj-2025-087045 · Cited by 23
Oestradiol and reproductive outcomes in ART: when too much of a good thing hurts
Bourdon, M., Maignien, C., Ouazana, M., Kefelian, F., Marcellin, L., Patrat, C., Pocate-Cheriet, K., Chapron, C., & Santulli, P. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.105131 · Cited by 16
Cycle management in frozen embryo transfer: the best of all worlds?
Roelens, C., & Blockeel, C. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104789 · Cited by 11
Polyzos, N. P. (2025) · Human Reproduction · doi:10.1093/humrep/deaf149 · Cited by 9
Metadata
- Authors
- Ho, V. N. A., Pham, T. D., Nguyen, N. T., Wang, R., Norman, R. J., Mol, B. W., Ho, T. M., & Vuong, L. N.
- Affiliations
- University of Medicine and Pharmacy at Ho Chi Minh City (VN)
- My Duc Hospital (VN)
- Monash Health (AU)
- The University of Adelaide (AU)
- University of Aberdeen (GB)
- Corresponding author
- Vuong, Lan N
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2024-07
- Volume
- 404
- Issue
- 10449
- Pages
- 266-275
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4400027247
- Cited by
- 55
- References
- 32
- Citations by year
- 2026: 28 · 2025: 24 · 2024: 3
- FWCI
- 37.06
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- frozen embryo transfer, endometrial preparation, natural cycle, modified natural cycle, artificial cycle, estradiol valerate, vaginal progesterone, human chorionic gonadotropin, ovulatory women, in vitro fertilization, embryo vitrification, endometrial receptivity, Vietnam, Ho Chi Minh City
- MeSH terms
- Adolescent, Adult, Embryo Transfer, Endometrium, Estradiol, Female, Fertilization in Vitro, Chorionic Gonadotropin, Humans, Middle Aged, Ovulation, Ovulation Induction, Pregnancy, Progesterone, Vietnam, Cryopreservation, Pregnancy Rate, Live Birth, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Livebirth rate after one frozen embryo transfer in ovulatory women starting with natural, modified natural, or artificial endometrial preparation in Viet Nam: an open-label randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(24)00756-6
- The paper
- Ho, V. N. A., Pham, T. D., Nguyen, N. T., Wang, R., Norman, R. J., Mol, B. W., Ho, T. M., & Vuong, L. N. (2024). Livebirth rate after one frozen embryo transfer in ovulatory women starting with natural, modified natural, or artificial endometrial preparation in Viet Nam: an open-label randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(24)00756-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.